Fig. 11From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitorsSchematic pathway for the synthesis of the target 2,5-disubstituted benzimidazoles 8a-uBack to article page